Events Calendar

Past Events

November 12-14, 2007 BIO-Europe
website
Hamburg, Germany
November 5-7, 2007 Acumen BioFin Rodman & Renshaw
9th Annual Healthcare Conference www.rodmanandrenshaw.com
Click here to link to the webcast
New York, NY
November 1, 2007 Final prostate cancer phase 1 results
Click Here
Webcast
October 9-11, 2007 BIO Investor Forum 2007
www.investorforum.bio.org
San Francisco, CA
October 3-5, 2007 BioContact
www.biocontact.qc.ca
Quebec City, QC
September 16-18, 2007
AdMeTech Conference
www..admetech.org
Washington, DC.
September 7, 2007
AUA South Central Section Meeting
www.scsauanet.org
Colarado Springs, CO
May 6 - 9, 2007 BIO 2007
www.bio2007.org
Boston, USA
Apr 24-26, 2007 BioFinance 2007
www.biofinance.ca
Toronto, Canada
Mar 12-14, 2007 BioSquare 2007
www.biosquare.com
Lyon, France
Jan 18, 2007 Conference Call on Prostate Cancer Trial Interim Results Vancouver, British Columbia
Nov 14-15, 2006 2006 Canadian Financing Forum West
http://www.financingforum.com/
Vancouver, British Columbia
Nov 7-10, 2006 18th EORTC-NCI-AACR Symposium
on Molecular Targets and
Cancer Therapeutics
Prague, Czech Republic
Oct 18-19, 2006 BIO Investor Forum
http://www.investorforum.bio.org/
San Francisco, California
Oct 5-6, 2006 Sachs Associates Biotech
in Europe Investor Forum
Zurich, Switzerland
Oct 4-6, 2006 BioContact
http://www.biocontact.qc.ca/
Quebec City, Quebec
June 22, 2006 Sachs Associates London
Biotech Investment Forum
http://www.sachsforum.com/
London, England
June 13, 2006 Fasken Martineau Technology
and Life Sciences Forum
Vancouver, British Columbia
May 1, 2006 BioFinance
http://www.biofinance.ca/
Toronto, Ontario 
Apr 9-12, 2006 BIO
http://www.bio2006.com/
Chicago, Illinois
Mar 21-22, 2006 Invest NorthWest
http://www.investnorthwest.org/
Webcast Available
Seattle, Washington
Feb 5-7, 2006 Biopartnering North America
www.techvision.com/bpn/
Vancouver, British Columbia

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39